Catalyst Wire Dossier Catalyst Wire Dossier

THS 2.2 Menthol

null · Philip Morris Products S.A.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for THS 2.2 Menthol, covering 2017-02-07 to 2017-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting [NA]

See pricing